Short-term alanyl-glutamine dipeptide pretreatment in liver ischemia–reperfusion model: Effects on microcirculation and antioxidant status in rats

SummaryBackground & aimsIschemia–reperfusion (I–R) injury is responsible for the morbidity associated with liver surgery. Production of toxic free radicals influences the microcirculation. The aim of our study was to examine the effect of glutamine (Gln) supplementation—adminstered in alanyl-glutamine dipeptide form—on liver function, immuno/histopathology and the oxidative state of the liver after injury.MethodsTwo-hundred and fifty grams male Wistar rats underwent normothermic, 60 min, segmental liver ischemia followed by 6 h of reperfusion. The animals (n=45) were divided into three groups: sham operated, I–R and parenteral Gln pretreatment. Hepatic microcirculation was monitored by laser Doppler flowmetry. At the 6 h of reperfusion, histological alterations, TUNEL reaction, active caspase-3 reaction, serum and liver tissue antioxidant levels, serum ALAT, ASAT and TNF-α levels were measured.ResultsUpon reperfusion, the Gln group had significantly (p<0.05) higher flow rates than the I–R group and, at the end of the 6 h of reperfusion, significantly (p<0.05) lower serum ALAT and ASAT levels. The liver chemiluminescent intensity was lower, free SH-groups were elevated, while the reducing power was decreased in the Gln-pretreated group. Positive staining for caspase-3 after Gln pretreatment was significantly increased in contrast to the control tissues.ConclusionGlutamine pretreatment is beneficial in supporting hepatic microcirculation and can prevent hepatocellular necrosis in liver reperfusion injury.